275 articles
Christopher Flowers, M.D., Department of Lymphoma - Myeloma, Division of Cancer Medicine and chair of Lymphoma & Myeloma at The University of Texas MD A...
Steve Marcus, CEO of Cantex Pharmaceuticals, a clinical-stage pharmaceutical company focused on developing transformative therapies for cancer and other...
Greg Pierce, SVP and GM of Specialty, Health & Wellness at Synchrony, a financial services company, discusses the over-the-counter (OTC) hearing aids ru...
Elizabeth Garner, MD, Chief Scientific Officer for Ferring Pharmaceuticals discusses C. Learn more on Health Professional Radio.
Corey Cutler, MD, MPH, FRCPC, Medical Director, Stem Cell Transplant Program, Dana-Farber Cancer Institute and Vice President, American Society for Tran...
Medical Advisor, Drug Monitoring and Toxicology at Quest Diagnostics discusses a report that he co-authored that found that one in two patients (49%) sh...
Mary Dubon, Physical Medicine and Rehabilitation at Massachusetts General Hospital discusses her recent presentation at the American Academy of Physical...
Richard Browne, MD, FACC, Senior Medical Executive, Health Systems Strategy and the Leader of the Cardiovascular Health Equity Advisory Council for Jans...
Gregory Flesher is President and CEO of Reneo Pharmaceuticals, a clinical-stage pharmaceutical company tackling the significant unmet need of developing...
Barbara Abernathy, a rare blood cancer survivor shares her experience with graft-versus-host disease (GVHD), a life-threatening condition that can occur...